Pfizer and other pandemic favorites in focus as FDA’s top vaccine regulator resigns

Pfizer (NYSE:PFE) and other pandemic-era favorites will be back in the investors’ crosshairs following the resignation of Dr. Peter Marks, the U.S. Food and Drug Administration’s (FDA) top vaccine regulator, on Friday.

Marks, who spearheaded regulatory efforts in approving COVID-19 vaccines